165 related articles for article (PubMed ID: 12595485)
1. Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae.
Ngamying M; Sawanpanyalert P; Butraporn R; Nikasri J; Cho SN; Levy L; Brennan PJ
Infect Immun; 2003 Mar; 71(3):1596-8. PubMed ID: 12595485
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.
Gelber RH; Murray L; Siu P; Tsang M
Infect Immun; 1992 May; 60(5):1840-4. PubMed ID: 1563772
[TBL] [Abstract][Full Text] [Related]
3. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
Gillis TP; Tullius MV; Horwitz MA
Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
[TBL] [Abstract][Full Text] [Related]
4. Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.
Gelber RH; Brennan PJ; Hunter SW; Munn MW; Monson JM; Murray LP; Siu P; Tsang M; Engleman EG; Mohagheghpour N
Infect Immun; 1990 Mar; 58(3):711-8. PubMed ID: 2407654
[TBL] [Abstract][Full Text] [Related]
5. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.
Bretscher PA
Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750
[TBL] [Abstract][Full Text] [Related]
6. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of mice against Mycobacterium leprae infection.
Singh NB; Lowe AC; Rees RJ; Colston MJ
Infect Immun; 1989 Feb; 57(2):653-5. PubMed ID: 2643581
[TBL] [Abstract][Full Text] [Related]
8. Searches among mycobacterial cultures for antileprosy vaccines.
Shepard CC; van Landingham R; Walker LL
Infect Immun; 1980 Sep; 29(3):1034-9. PubMed ID: 7000701
[TBL] [Abstract][Full Text] [Related]
9. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
10. [Development of antileprosy vaccines].
Kalianina OV; Iushchenko AA
Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):93-100. PubMed ID: 15881952
[TBL] [Abstract][Full Text] [Related]
11. [Vaccination against leprosy].
Grosset J; Lecoeur H
Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467
[No Abstract] [Full Text] [Related]
12. Effects of vaccination with several mycobacterial proteins and lipoproteins on Mycobacterium leprae infection of the mouse.
Ngamying M; Varachit P; Phaknilrat P; Levy L; Brennan PJ; Cho SN
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):43-5. PubMed ID: 11480318
[No Abstract] [Full Text] [Related]
13. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.
Gelber RH; Mehra V; Bloom B; Murray LP; Siu P; Tsang M; Brennan PJ
Infect Immun; 1994 Oct; 62(10):4250-5. PubMed ID: 7927681
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the multiplication of Mycobacterium leprae by vaccination with a recombinant M. bovis BCG strain that secretes major membrane protein II in mice.
Maeda Y; Tamura T; Matsuoka M; Makino M
Clin Vaccine Immunol; 2009 Oct; 16(10):1399-404. PubMed ID: 19675226
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.
Roche PW; Neupane KD; Britton WJ
Clin Exp Immunol; 1992 Jul; 89(1):110-4. PubMed ID: 1628419
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of mice against the leprosy bacillus with skin-test antigens.
Ngamying M; Levy L; Brennan PJ
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):305-7. PubMed ID: 10575412
[No Abstract] [Full Text] [Related]
17. Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae.
Baumgart KW; McKenzie KR; Radford AJ; Ramshaw I; Britton WJ
Infect Immun; 1996 Jun; 64(6):2274-81. PubMed ID: 8675337
[TBL] [Abstract][Full Text] [Related]
18. The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice.
Naito M; Matsuoka M; Ohara N; Nomaguchi H; Yamada T
Vaccine; 1999 Dec; 18(9-10):795-8. PubMed ID: 10580191
[TBL] [Abstract][Full Text] [Related]
19. Regarding analysis of vaccines.
Convit J
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):576-7. PubMed ID: 8642226
[No Abstract] [Full Text] [Related]
20. Vaccination in leprosy--observations and interpretations.
Convit J; Ulrich M; Aranzazu N
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):62-5. PubMed ID: 6988347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
